RSS   Newsletter   Contact   Advertise with us
Post Online Media

AzurRx BioPharma adds Charles J Casamento to board

Charles J CasamentoAzurRx BioPharma, a biopharmaceutical company, announced the appointment of Charles J Casamento to the board of directors.
Article continues below

READ MORE Relmada Therapeutics appoints Charles J. Casamento to board

Since 2007 Mr. Casamento has been executive director and principal of The Sage Group, a health care advisory group. He was president and CEO of Osteologix from October 2004 until April 2007.

Mr. Casamento was the founder of Questcor Pharmaceuticals where he was president, CEO and chairman. At Questcor he acquired Acthar.

At RiboGene Inc. Mr. Casamento was president, CEO and chairman and he was also co-founder, president and CEO of Indevus (formerly Interneuron Pharmaceuticals).

Mr. Casamento has held senior management positions at Genzyme Corporation, where he was Senior Vice President, American Hospital Supply, where he was Vice President of Business Development for the Critical Care division, Johnson & Johnson, Hoffmann-LaRoche and Sandoz.

Mr. Casamento holds a bachelor's degree in Pharmacy from Fordham University and an M.B.A. from Iona College.

He currently sits on the Boards of Directors of International Stem Cell Corporation and Relmada Therapeutics.

 LATEST MOVES FROM New York 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy